Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Could the now popular weight-loss injection drugs be a solution for ... In this respect, the use of liraglutide in children with an extreme form of obesity could be a significant supplementary ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide ... use of GLP-1 drugs has soared ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...

Most were prescribed a GLP-1 drug for type 2 diabetes management, but about 18% were taking either liraglutide or semaglutide for obesity. The researchers found that one year after taking these ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Semaglutide is better known as Ozempic, approved to treat type 2 diabetes, and Wegovy, for obesity; liraglutide is approved ... thoughts among people using the drugs, but both thus far have ...